Literature DB >> 12669120

Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases.

Tomohiro Sase1, Hideo Wada, Junji Nishioka, Yasunori Abe, Esteban C Gabazza, Hiroshi Shiku, Koji Suzuki, Sin Nakamura, Tsutomu Nobori.   

Abstract

In a preliminary study, we have demonstrated that tissue factor (TF) is immunohistochemically stained in monocytes from patients with disseminated intravascular coagulation (DIC) but not from healthy volunteers, and that leukocytes from DIC patients induce enhanced activated factor X (FXa) generation in the presence of a mixture of FVIIa, FX and Ca(2+). Then, TF mRNA levels in leukocytes were measured to evaluate the role of TF in the pathophysiology of various diseases. TF mRNA levels in leukocytes were low in healthy volunteers but they were significantly increased in various diseases, especially in patients with infectious diseases, solid cancer, and hematopoietic tumors. TF mRNA levels in leukocytes were significantly higher in patients with high levels of C reactive protein (CRP) than in those with low CRP. TF mRNA levels were significantly higher in patients with DIC than in those without DIC. TF mRNA levels were well correlated with TF antigens in plasma and leukocytes. These findings suggest that the expression of TF mRNA in leukocytes is increased in various diseases and that this may play an important role in hypercoagulability or DIC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12669120

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

Review 1.  Role of tissue factor in thrombosis in antiphospholipid antibody syndrome.

Authors:  J Boles; N Mackman
Journal:  Lupus       Date:  2010-04       Impact factor: 2.911

2.  Prevalence and clinical characteristics of acute myeloid leukemia associated with disseminated intravascular coagulation.

Authors:  Hideki Uchiumi; Takafumi Matsushima; Arito Yamane; Noriko Doki; Hiroyuki Irisawa; Takayuki Saitoh; Tohru Sakura; Takahiro Jimbo; Hiroshi Handa; Norifumi Tsukamoto; Masamitsu Karasawa; Shuichi Miyawaki; Hirokazu Murakami; Yoshihisa Nojima
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

3.  Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.

Authors:  Nicola Semeraro; Concetta T Ammollo; Fabrizio Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-13       Impact factor: 2.576

4.  Acute disseminated intravascular coagulation following ICD lead extraction.

Authors:  Nasir Shariff; Madhurmeet Singh; Alaa Shalaby
Journal:  BMJ Case Rep       Date:  2014-03-05

5.  Sequential chemotherapy with methotrexate and 5-fluorouracil for chemotherapy-naive advanced gastric cancer with disseminated intravascular coagulation at initial diagnosis.

Authors:  Atsuo Takashima; Kuniaki Shirao; Yoshinori Hirashima; Daisuke Takahari; Natsuko T Okita; Takako E Nakajima; Ken Kato; Tetsuya Hamaguchi; Yasuhide Yamada; Yasuhiro Shimada
Journal:  J Cancer Res Clin Oncol       Date:  2010-02       Impact factor: 4.553

6.  Thrombomodulin phenotype of a distinct monocyte subtype is an independent prognostic marker for disseminated intravascular coagulation.

Authors:  Sang Mee Hwang; Ji-Eun Kim; Kyou-Sup Han; Hyun Kyung Kim
Journal:  Crit Care       Date:  2011-04-14       Impact factor: 9.097

Review 7.  Differences and similarities between disseminated intravascular coagulation and thrombotic microangiopathy.

Authors:  Hideo Wada; Takeshi Matsumoto; Kei Suzuki; Hiroshi Imai; Naoyuki Katayama; Toshiaki Iba; Masanori Matsumoto
Journal:  Thromb J       Date:  2018-07-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.